Cartesian Therapeutics Files Q1 2026 10-Q
Ticker: RNAC · Form: 10-Q · Filed: Apr 30, 2026 · CIK: 0001453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials, employment-agreement
TL;DR
Cartesian Therapeutics filed its Q1 2026 10-Q on 4/30/26. Check financials & employment agreements.
AI Summary
Cartesian Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing includes financial statements and exhibits such as an employment agreement. The company's SEC accession number is 0001453687-26-000082, and the filing date was April 30, 2026.
Why It Matters
This filing provides investors with an update on Cartesian Therapeutics' financial performance and operational status for the first quarter of 2026.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not appear to contain significant new risks or negative developments.
Key Numbers
- 1001035 — iXBRL 10-Q Size (Size of the interactive data 10-Q document)
- 12680814 — Complete submission text file Size (Size of the complete submission text file)
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Filer of the 10-Q report
- 0001453687-26-000082 (other) — SEC Accession Number for the filing
- 2026-04-30 (date) — Filing Date
- 2026-03-31 (date) — Period of Report
FAQ
What is the primary purpose of this 10-Q filing?
The primary purpose is to provide a quarterly report on the financial condition and operations of Cartesian Therapeutics, Inc. for the period ending March 31, 2026.
When was this 10-Q filing accepted by the SEC?
This 10-Q filing was accepted by the SEC on April 30, 2026.
What is the SEC accession number for this filing?
The SEC accession number for this filing is 0001453687-26-000082.
What types of exhibits are included with this 10-Q filing?
The exhibits include an employment agreement (EX-10.1) and certifications (EX-31.1, EX-31.2, EX-32.1), along with associated graphic files.
What period does the financial information in this report cover?
The financial information in this report covers the period ending March 31, 2026.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2026 regarding Cartesian Therapeutics, Inc. (RNAC).